1)Pedrazzoli S, DiCarlo V, Dionigi R, et al:Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas:a multicenter, prospective, randomized study. Ann Surg 228:508-517, 1998
2)Yeo CJ, Cameron JL, Lillemoe KD, et al:Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2, randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 236:355-366, 2002
3)Farnell MB, Pearson RK, Sarr MG, et al:A prospective randomized comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 138:618-628, 2005
4)Nimura Y, Nagino M, Takao S, et al:Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas:long-term results of a Japanese multicenter randomized controlled trial. J Hepatobiliary Pancreat Sci 19:230-241, 2012
5)Jang JY, Kang JS, Han Y, et al:Long-term outcomes and recurrence patterns of standard versus extended pancreatectomy for pancreatic head cancer:a multicenter prospective randomized controlled study. J Hepatobiliary Pancreat Sci 24:426-433, 2017
6)Wang XX, Yan YK, Dong BL, et al:Pancreatic outflow tract reconstruction after pancreaticoduodenectomy:a meta-analysis of randomized controlled trials. World J Surg Oncol 19:203, 2021 doi:10.1186/s12957-021-02314-2
7)Keck T, Wellner UF, Bahra M, et al:Pancreatogastrostomy versus pancreatojejunostomy for reconstruction after pancreatoduodenectomy(RCOPANC, DRKS 00000767):perioperative and long-term results of a multicenter randomized controlled trial. Ann Surg 263:440-449, 2016
8)Kwak BJ, Choi HJ, You YK, et al:Comparative long-term outcomes for pancreatic volume change, nutritional status, and incidence of new-onset diabetes between pancreatogastrostomy and pancreatojejunostomy after pancreaticoduodenectomy. Hepatobiliary Surg Nutr 9:284-295, 2020
9)Giovinazzo F, Turri G, Katz MH, et al:Meta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma. Br J Surg 103:179-191, 2016
10)Machairas N, Raptis DA, Velazquez PS, et al:The impact of neoadjuvant therapy on survival in patients undergoing pancreatoduodenectomy with concomitant portomesenteric venous resection:a international multicenter analysis. Ann Surg 274:721-728, 2021
11)Hachert T, Klaiber U, Hinz U, et al:Portal vein resection in pancreatic cancer surgery:risk of thrombosis and radicality determined survival. Ann Surg 277:e1291-e1298, 2023
12)Song W, Yang Q, Chen L, et al:Pancreatoduodenectomy combined with portal-superior mesenteric vein resection and reconstruction with interposition grafts for cancer:a meta-analysis. Oncotarget 8:81520-81528, 2017
13)Mizuno S, Kato H, Yamaue H, et al:Left-sided portal hypertension after pancreaticoduodenectomy with resection of the portal vein/superior mesenteric vein confluence in patients with pancreatic cancer. Ann Surg 274:e36-e44, 2021
14)Sharpe SM, Talamonti MS, Wang CE, et al:Early national experience with laparoscopic pancreaticoduodenectomy for ductal adenocarcinoma:a comparison of laparoscopic pancreaticoduodenectomy and open pancreaticoduodenectomy from the national cancer data base. J Am Coll Surg 221:175-184, 2015
15)Weng Y, Jiang Y, Fu N, et al:Oncological outcomes of robotic-assisted versus open pancreatoduodenectomy for pancreatic ductal adenocarcinoma:a propensity score-matched analysis. Surg Endosc 35:3437-3448, 2021
16)Sun R, Yu J, Zhang Y, et al:Perioperative and oncological outcomes following minimally invasive versus open pancreaticoduodenectomy for pancreatic duct adenocarcinoma. Surg Endosc 35:2273-2285, 2021